Skip to main content
Cenra Inc. logo

Cenra Inc. — Investor Relations & Filings

Ticker · 3716 ISIN · TW0003716007 TW Manufacturing
Open in API
Filings indexed 399 across all filing types
Latest filing 2025-03-31 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 3716

About Cenra Inc.

https://www.cenra.com/

Cenra Inc. is a diversified healthcare enterprise with a history dating back to 1952. The company operates across a comprehensive value chain encompassing research and development, manufacturing, commercial marketing, and long-term care services. Its extensive portfolio includes active pharmaceutical ingredients (APIs), human pharmaceuticals, animal health products, and consumer health brands such as dietary supplements and personal care items. With a global reach spanning over 60 markets, the organization utilizes nine production bases and more than ten specialized technology platforms to deliver integrated health solutions. Cenra Inc. focuses on high-barrier oncology medications, complex generics, and 505(b)(2) drug developments. By integrating scientific innovation with rigorous operational management, the company provides accessible medical care and health services designed to meet evolving needs across all life stages.

Recent filings

Filing Released Lang Actions
113年第4季資產負債表
Interim / Quarterly Report Classification · 85% confidence The document contains a consolidated balance sheet with detailed financial data for the fourth quarter of the 113th year (likely referring to a fiscal year in the Taiwanese calendar, corresponding to 2024). It includes comprehensive financial statement items such as assets, liabilities, equity, and detailed line items with amounts and percentages. The document is about 3894 characters long, which is relatively short but contains substantive financial data rather than just an announcement or a certification. There is no indication that this is a full annual report or an interim report covering multiple financial statements and management discussion, but the presence of a full balance sheet for a quarter suggests it is a quarterly or interim financial report. Given the detailed financial data for a specific quarter and the nature of the content, the document best fits the category of an Interim / Quarterly Report (IR). FY 2024
2025-03-31 Chinese
113年第4季綜合損益表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated comprehensive income statement for the fourth quarter of the 113th year (which corresponds to 2024 in the Gregorian calendar) and comparative data for the previous year. It includes detailed financial figures such as revenue, costs, expenses, net income, and earnings per share. The presence of actual financial data and the quarterly period reference indicate this is a financial report for a period shorter than a full fiscal year. The document length is 2706 characters, which is relatively short but contains substantive financial data, not just an announcement or a certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). FY 2024
2025-03-31 Chinese
113年第4季現金流量表
Interim / Quarterly Report Classification · 95% confidence The document contains a detailed consolidated cash flow statement for the fourth quarter of the 113th year (likely referring to the Taiwanese calendar year 2024). It includes comprehensive financial data such as cash flows from operating, investing, and financing activities, with specific monetary amounts and accounting items. The presence of actual financial statements and substantive financial data for a quarterly period indicates this is a financial report rather than an announcement or certification. The document length is under 5,000 characters but contains detailed financial data, so it is not a mere report publication announcement. Given the quarterly period and detailed financial data, the document fits the definition of an Interim / Quarterly Report (IR). FY 2024
2025-03-31 Chinese
113年度應收帳款周轉率
Regulatory Filings Classification · 90% confidence The document is very short (304 characters) and contains a brief financial metric table with turnover ratios and average collection days for a company named 中化控股, previously 中化投資控股股份有限公司. There is no detailed financial report, no comprehensive analysis, no regulatory body mention, no fiscal period report, and no indication of a full report or announcement of a meeting or voting results. The content is a simple data disclosure likely related to a regulatory or public information disclosure platform. Given the brevity and nature, it does not qualify as a full Annual Report, Interim Report, or Earnings Release. It is not a certification or officer attestation. It is not a report publication announcement since it contains actual data, but the data is minimal and does not constitute a full financial report. The best fit is Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other categories.
2025-03-31 Chinese
113年度存貨週轉率
Regulatory Filings Classification · 95% confidence The document is very short (301 characters) and contains a brief data table with inventory turnover rates and average sales days for two fiscal years. There is no detailed financial statement, management discussion, or comprehensive report content. It appears to be a simple data disclosure or regulatory announcement related to inventory metrics. Given the brevity and nature of the content, it does not qualify as a full Annual Report, Interim Report, or Earnings Release. It also does not fit into categories like Board changes, M&A, or Governance. The document is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2025-03-31 Chinese
113年度毛利率
Regulatory Filings Classification · 95% confidence The document is very short (392 characters) and contains a brief financial summary table with annual revenue, cost, gross profit, and gross margin percentages for two years (112 and 113). It also includes a note about explaining significant changes in gross margin. There is no detailed financial statement, management discussion, or comprehensive report content. The document appears to be a brief financial data update rather than a full report. Given the short length and summary nature, it fits best as a Regulatory Filing (RNS) which is a fallback category for miscellaneous filings that do not fit other specific categories.
2025-03-31 Chinese

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.